Efficacy of the Cardiac Implantable Electronic Device Multisensory Triage-HF Algorithm in Heart Failure Care: A Real-World Clinical Experience

被引:0
|
作者
Aslan, Ugur [1 ]
Beeres, Saskia L. M. A. [1 ]
Feijen, Michelle [1 ]
Mulder, Gerlinde M. [1 ]
Jukema, J. Wouter [1 ,2 ]
Egorova, Anastasia D. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Cardiol, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands
[2] Netherlands Heart Inst, Morseelsepk 1, NL-3511 EP Utrecht, Netherlands
关键词
cardiac implantable electronic device; multisensory algorithm; heart failure; telemonitoring; remote monitoring; RISK; HOSPITALIZATION; VALIDATION; MORTALITY; EVENTS; ALERTS;
D O I
10.3390/s24113664
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Heart failure (HF) admissions are burdensome, and the mainstay of prevention is the timely detection of impending fluid retention, creating a window for medical treatment intensification. This study evaluated the accuracy and performance of a Triage-HF-guided carepath in real-world ambulatory HF patients in daily clinical practice. In this prospective, observational study, 92 adult HF patients (71 males (78%), with a median age of 69 [IQR 59-75] years) with the Triage-HF algorithm activated in their cardiac implantable electronic devices (CIEDs), were monitored. Following high-risk alerts, an HF nurse contacted patients to identify signs and symptoms of fluid retention. The sensitivity and specificity were 83% and 97%, respectively. The positive predictive value was 89%, and negative predictive value was 94%. The unexplained alert rate was 0.05 alerts/patient year, and the false negative rate was 0.11 alerts/patient year. Ambulatory diuretics were initiated or escalated in 77% of high-risk alert episodes. In 23% (n = 6), admission was ultimately required. The median alert handling time was 2 days. Fifty-eight percent (n = 18) of high-risk alerts were classified as true positives in the first week, followed by 29% in the second-third weeks (n = 9), and 13% (n = 4) in the fourth-sixth weeks. Common sensory triggers included an elevated night ventricular rate (84%), OptiVol (71%), and reduced patient activity (71%). The CIED-based Triage-HF algorithm-driven carepath enables the timely detection of impending fluid retention in a contemporary ambulatory setting, providing an opportunity for clinical action.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Safety of continuous use of Apixaban, Rivaroxaban and Dabigatran in patients undergoing cardiac implantable electronic device implantation in a real-world cohort
    Huemer, M.
    Attanasio, P. A.
    Ben Ltaief, K. B. L.
    Nagel, P. N.
    Biewener, S.
    Suhail, S.
    Lenz, K.
    Landmesser, U.
    Roser, M.
    Tscholl, V.
    EUROPEAN HEART JOURNAL, 2018, 39 : 832 - 832
  • [22] Real-world survey of post-operative cardiac implantable electronic device (CIED) complications reported by the electrophysiology team in 2022
    Shoukri, Nolan
    Barefoot, Nathan
    Haines, David E. E.
    Stein, Kenneth M. M.
    Mehta, Nishaki K. K.
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2023, 66 (07) : 1567 - 1569
  • [23] Real-world survey of post-operative cardiac implantable electronic device (CIED) complications reported by the electrophysiology team in 2022
    Nolan Shoukri
    Nathan Barefoot
    David E. Haines
    Kenneth M. Stein
    Nishaki K. Mehta
    Journal of Interventional Cardiac Electrophysiology, 2023, 66 : 1567 - 1569
  • [24] Prospective Implementation of a Cardiovascular Implantable Electronic Device Algorithm-Based Management Pathway in Routine Heart Failure Care
    Kratka, Allison
    Rohrbach, Greg
    Puckett, Margaret
    Rotering, Thomas
    Raitt, Merritt
    Whooley, Mary
    Dhruva, Sanket
    CIRCULATION, 2024, 150
  • [25] Overcoming challenges in adopting guideline-based device therapy in patients with heart failure; a real-world experience
    Malaweera, A.
    Kanthasamy, V.
    Church, H.
    Veasey, R. A.
    Marshall, A. J.
    Hunt, J.
    Patel, N. R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 525 - 526
  • [26] Gain in real-world cardiac resynchronization therapy efficacy with SyncAV dynamic optimization: Heart failure hospitalizations and costs
    Varma, Niraj
    Hu, Yajing
    Connolly, Allison T.
    Thibault, Bernard
    Singh, Balbir
    Mont, Lluis
    Nabutovsky, Yelena
    Zareba, Wojciech
    HEART RHYTHM, 2021, 18 (09) : 1577 - 1585
  • [27] Impact of sacubitril/valsartan on implantable defibrillator eligibility in heart failure: a real-world experience (vol 25, pg 5690, 2021)
    Monzo, L.
    Gaudio, C.
    Cicogna, F.
    Tota, C.
    Petronilli, V.
    Mennuni, S.
    De Ruvo, E.
    Calo, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (07) : 2216 - 2216
  • [28] Clinical efficacy of a device to narrow the coronary sinus for the treatment of refractory angina a single center real-world experience
    Agostoni, P.
    EUROPEAN HEART JOURNAL, 2015, 36 : 1090 - 1090
  • [29] Clinical inertia in heart failure care - Should we worry? Insights from "real-world" practice
    Cabral, Sofia
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2023, 42 (02) : 97 - 99
  • [30] Choice of cardiac implantable electronic device and age-stratified clinical outcome in patients with known heart failure prior to implant
    Rorsman, C.
    Farouq, M.
    Marinko, S.
    Platonov, P. G.
    Chaudhry, U.
    Mortsell, D.
    Wang, L.
    Borgquist, R.
    EUROPEAN HEART JOURNAL, 2023, 44